Jonathan P. Caulkins — Publications
-
America's Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms
2023
-
The Ecosystem Approach to Opioid Policy
2023
-
How Much Illegally Manufactured Fentanyl Could the U.S. Be Consuming?
2022
-
Rapid Changes in Illegally Manufactured Fentanyl Products and Prices in the United States
2022
-
Cannabis Legalization and Social Equity: Some Opportunities, Puzzles, and Trade-Offs
2021
-
Heroin Use Cannot Be Measured Adequately with a General Population Survey
2021
-
The Dawn of a New Synthetic Opioid Era: The Need for Innovative Interventions
2020
-
Variation in the Degree of Concentration of Prescription Opioid Utilization Using Different Measures
2020
-
After the Grand Opening: Assessing Cannabis Supply and Demand in Washington State
2019
-
The Future of Fentanyl and Other Synthetic Opioids
2019
-
Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence
2019
-
The Synthetic Opioid Surge in the United States: Insights from Mortality and Seizure Data
2019
-
Triangulating Web & General Population Surveys: Do Results Match Legal Cannabis Market Sales?
2019
-
Understanding America's Surge in Fentanyl and Other Synthetic Opioids
2019
-
What America's Users Spend on Illegal Drugs, 2006–2016
2019
-
Acceptability of Heroin-Assisted Treatment and Supervised Drug Consumption Sites to Address the Opioid Crisis in the United States: Key Informant Perspectives
2018
-
Assessing the Evidence on Supervised Drug Consumption Sites
2018
-
Big Data on a Big New Market: Insights from Washington State's Legal Cannabis Market
2018
-
Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States
2018
-
Variation in Cannabis Potency and Prices in a Newly Legal Market: Evidence from 30 Million Cannabis Sales in Washington State
2017
-
Considering Marijuana Legalization Carefully: Insights for Other Jurisdictions from Analysis for Vermont
2016
-
Marijuana Legalization: What Everyone Needs to Know (Second Edition)
2016
-
Modeling the Structure and Operation of Drug Supply Chains: The Case of Cocaine and Heroin in Italy and Slovenia
2016
-
Beyond Prevalence: Importance of Estimating Drug Consumption and Expenditures
2015
-
Cocaine's Fall and Marijuana's Rise: Questions and Insights Based on New Estimates of Consumption and Expenditures in U. S. Drug Markets
2015
-
Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions
2015
-
How Much of the Cocaine Market Are We Missing? Insights from Respondent-Driven Sampling in a Mid-Sized American City
2015
-
The Marijuana Legalization Debate: Insights for Vermont
2015
-
Options and Issues Regarding Marijuana Legalization
2015
-
Are Users' Most Recent Drug Purchases Representative?
2014
-
Criminal Justice Costs of Prohibiting Marijuana in California
2014
-
Developing Public Health Regulations for Marijuana: Lessons from Alcohol and Tobacco
2014
-
How Big Is the U.S. Market for Illegal Drugs?
2014
-
What America's Users Spend on Illegal Drugs: 2000–2010
2014
-
Before the Grand Opening: Measuring Washington State's Marijuana Market in the Last Year Before Legalized Commercial Sales
2013
-
Estimating the Size of the EU Cannabis Market
2013
-
High Tax States: Options for Gleaning Revenue from Legal Cannabis
2013
-
Multinational overview of cannabis production regimes
2013
-
Quasi-legal Cannabis in Colorado and Washington: Local and National Implications
2013
-
Statistics on Cannabis Users Skew Perceptions of Cannabis Use
2013
-
The Whole Is Just the Sum of Its Parts: Limited Polydrug Use Among the "Big Three" Expensive Drugs in the United States
2013
-
Design Considerations for Legalizing Cannabis: Lessons Inspired by Analysis of California's Proposition 19
2012
-
Epidemiological Model for Examining Marijuana Use Over the Life Course
2012
-
Scheduling of Newly Emerging Drugs: A Critical Review of Decisions Over 40 Years
2012
-
The U.S. Drug Policy Landscape: Insights and Opportunities for Improving the View
2012
-
Addiction Research Centres and the Nurturing of Creativity: RAND's Drug Policy Research Center
2011
-
Basing Drug Scheduling Decisions on Scientific Ranking of Harmfulness: False Promise from False Premises
2011
-
Bringing Perspective to Illicit Markets: Estimating the Size of the U.S. Marijuana Market
2011
-
Budgeting for Immigration Enforcement: A Path to Better Performance
2011
-
Altered State? Assessing How Marijuana Legalization in California Could Influence Marijuana Consumption and Public Budgets
2010
-
Cost of Marijuana Prohibition on the California Criminal Justice System
2010
-
Estimated Cost of Production for Legalized Cannabis
2010
-
How Might Marijuana Legalization in California Affect Drug Trafficking Revenues and Violence in Mexico?
2010
-
How Might Marijuana Legalization in California Affect Public Budgets and Marijuana Consumption?
2010
-
Potential for Legal Marijuana Sales in California to Supply Rest of U.S.
2010
-
RAND Review: Vol. 34, No. 2, Summer 2010
2010
-
Reducing Drug Trafficking Revenues and Violence in Mexico: Would Legalizing Marijuana in California Help?
2010
-
Smuggling and Excise Tax Evasion for Legalized Marijuana: Lessons from Other Excise Taxes
2010
-
What Economics Can Contribute to the Addiction Sciences
2010
-
Marijuana Markets: Inferences from Reports by the Household Population
2006
-
Assessing U.S. Drug Problems and Policy: A Synthesis of the Evidence to Date
2005
-
How Goes the “War on Drugs”? An Assessment of U.S. Drug Problems and Policy
2005
-
Models Pertaining to How Drug Policy Should Vary Over the Course of a Drug Epidemic
2005
-
What We Can--And Cannot--Expect from School-Based Drug Prevention
2004
-
Crash Courses: Hard Lessons from Educational Interventions
2003
-
Drug Use and Drug Policy Futures: Insights from a Colloquium
2003
-
International Drug Prices: Evidence from STRIDE
2003
-
RAND Review: Vol. 27, No. 1, Spring 2003
2003
-
Intelligent Giving: Insights and Strategies for Higher Education Donors
2002
-
Law Enforcement's Role in a Harm Reduction Regime
2002
-
A "Noble Bet" in Early Care and Education: Lessons from One Community's Experience
2002
-
A "Noble Bet" in Early Care and Education: Lessons from One Community's Experience: Executive Summary
2002
-
School-Based Drug Prevention: What Kind of Drug Use Does It Prevent?
2002
-
What Are the True Benefits of School-Based Drug Prevention Programs?
2002
-
Analyzing the Costs and Benefits of Early Childhood Interventions
2001
-
Assessing Costs and Benefits of Early Childhood Intervention Programs: Overview and Applications to the Starting Early, Starting Smart Program: Executive Summary
2001
-
Assessing Costs and Benefits of Early Childhood Intervention Programs: Overview and Applications to the Starting Early, Starting Smart Program
2001
-
Drug Prices and Emergency Department Mentions for Cocaine and Heroin
2001
-
The Evolution of Drug Initiation: From Social Networks to Public Markets
2001
-
Do Drug Prohibition and Enforcement Work?
2000
-
A Dynamic Model of Drug Initiation: Implications for Treatment and Drug Control
2000
-
The Global Course of the Information Revolution: Technological Trends: Proceedings of an International Conference
2000
-
Measurement and Analysis of Drug Problems and Drug Control Efforts
2000
-
Optimal Control of Drug Epidemics: Prevent and Treat--But Not at the Same Time?
2000
-
Response to the National Research Council's Assessment of RAND's "Controlling Cocaine" Study
2000
-
Should the U.S. Direct More Law Enforcement Effort at XTC?
2000
-
The Benefits and Costs of Drug Use Prevention: Clarifying a Cloudy Issue
1999
-
An Ounce of Prevention, a Pound of Uncertainty: The Cost-Effectiveness of School-Based Drug Prevention Programs
1999
-
Are mandatory minimum drug sentences cost-effective?
1998
-
Can difficult-to-reuse syringes reduce the spread of HIV among injection drug users?
1998
-
Is crack cheaper than (powder) cocaine?
1998
-
Modeling the domestic distribution network for illicit drugs
1998
-
Are Mandatory Minimum Drug Sentences Cost-Effective?
1997
-
Enforcement or Treatment? : Modeling the Relative Efficacy of Alternatives for Controlling Cocaine
1997
-
Examining the Behavioral Assumptions of the National Drug Control Strategy
1997
-
Mandatory Minimum Drug Sentences: Throwing Away the Key or the Taxpayers' Money?
1997
-
The Meaning and Utility of Drug Prices
1997
-
Setting Goals for Drug Policy: Harm Reduction or Use Reduction?
1997
-
What does mathematical modeling tell us about harm reduction?
1997
-
Cocaine consumption in the United States : estimating past trends and future scenarios
1996
-
Describing DAWN's dominion
1996
-
Can the Military Help Prevent Drug Use Among Youth?
1995
-
Dealing with the country's drug problem
1995
-
Domestic Geographic Variation in Illicit Drug Prices
1995
-
Evaluating the effectiveness of interdiction and source country control
1995
-
Redefining the Goals of National Drug Policy: Recommendations from a Working Group
1995
-
To How Many Customers Should a Drug Dealer Sell?
1995
-
Developing Price Series for Cocaine
1994
-
Examining the Behaviorial Assumptions of the National Drug Control Strategy
1994
-
Improving Data and Analysis to Support National Drug Abuse Policy — Main Report
1994
-
Preventing Drug Use Among Youth Through Community Outreach: The Military's Pilot Programs
1994
-
Three Strikes and You’re Out: Estimated Benefits and Costs of California’s New Mandatory-Sentencing Law
1994
-
What is the Average Price of an Illicit Drug?
1994
-
Improving Data and Analysis to Support National Substance Abuse Policy
1993
-
ONDCP’s First Four Years as a Policy Agency
1993
-
Simulation of Adaptive Response: A Model of Drug Interdiction
1993
